NanoRepro Balance Sheet Health
Financial Health criteria checks 6/6
NanoRepro has a total shareholder equity of €39.0M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €39.7M and €727.6K respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €25.80m |
| Equity | €39.02m |
| Total liabilities | €727.61k |
| Total assets | €39.75m |
Recent financial health updates
Recent updates
Cautious Investors Not Rewarding NanoRepro AG's (ETR:NN6) Performance Completely
Mar 01
The Market Lifts NanoRepro AG (ETR:NN6) Shares 28% But It Can Do More
Sep 13A Look At The Intrinsic Value Of NanoRepro AG (ETR:NN6)
Aug 04NanoRepro (ETR:NN6) Is Experiencing Growth In Returns On Capital
Apr 12NanoRepro (ETR:NN6) Is Doing The Right Things To Multiply Its Share Price
Dec 15Robust Earnings May Not Tell The Whole Story For NanoRepro (ETR:NN6)
May 29NanoRepro AG's (ETR:NN6) Stock Is Going Strong: Have Financials A Role To Play?
Jan 04Financial Position Analysis
Short Term Liabilities: NN6's short term assets (€31.1M) exceed its short term liabilities (€418.4K).
Long Term Liabilities: NN6's short term assets (€31.1M) exceed its long term liabilities (€309.2K).
Debt to Equity History and Analysis
Debt Level: NN6 is debt free.
Reducing Debt: NN6 has no debt compared to 5 years ago when its debt to equity ratio was 0.05%.
Debt Coverage: NN6 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NN6 has no debt, therefore coverage of interest payments is not a concern.